Cargando…
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19
Advanced age or preexisting comorbidities have been characterized as risk factors for severe coronavirus disease 2019 (COVID-19) cases requiring hospitalization and intensive care. In recent years, clonal hematopoiesis (CH) of indeterminate potential (CHIP) has emerged as a risk factor for chronic i...
Autores principales: | Duployez, Nicolas, Demonchy, Jordane, Berthon, Céline, Goutay, Julien, Caplan, Morgan, Moreau, Anne-Sophie, Bignon, Anne, Marceau-Renaut, Alice, Garrigue, Delphine, Raczkiewicz, Imelda, Geffroy, Sandrine, Bucci, Maxime, Alidjinou, Kazali, Demaret, Julie, Labalette, Myriam, Brousseau, Thierry, Dupont, Annabelle, Rauch, Antoine, Poissy, Julien, Susen, Sophie, Preudhomme, Claude, Quesnel, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409316/ https://www.ncbi.nlm.nih.gov/pubmed/32708264 http://dx.doi.org/10.3390/cancers12071992 |
Ejemplares similares
-
Pharmacokinetics of enoxaparin in COVID-19 critically ill patients
por: Zufferey, Paul Jacques, et al.
Publicado: (2021) -
Spatial and Temporal Virus Load Dynamics of SARS-CoV-2: A Single-Center Cohort Study
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2021) -
Sensitivity of SARS-CoV-2 variant Delta to serum neutralization in BNT162b2 vaccinees and unvaccinated COVID-19 recovered cases
por: Alidjinou, Enagnon Kazali, et al.
Publicado: (2021) -
Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variants
por: Hirabidian, Mickael, et al.
Publicado: (2022) -
Severe SARS‐CoV‐2 patients develop a higher specific T‐cell response
por: Demaret, Julie, et al.
Publicado: (2020)